首页 | 本学科首页   官方微博 | 高级检索  
     

更昔洛韦的体外抗乙肝病毒活性
引用本文:黄砚青,龚作炯,蔡鸿生,罗顺德. 更昔洛韦的体外抗乙肝病毒活性[J]. 中国医院药学杂志, 2000, 20(10): 589-592
作者姓名:黄砚青  龚作炯  蔡鸿生  罗顺德
作者单位:湖北医科大学附属第一医院,湖北武汉430060
摘    要:目的:评价更昔洛韦(GCV)体外抗乙肝病毒(HBV)活性。方法:应用HBV DNA转染的人肝癌细胞株(HepG22.2.15),进行GCV体外抗HBV活性的研究。结果:GCV能明显减少HepG22.2.15细胞培养上清液中HBsAg、HBV DNA的产生。Southern印迹法分析:GCV能显著抑制HBV复制中间体(包括共价闭合环状态DNA),而同时该药物对细胞形态、细胞计数及总细胞DNA无明显的

关 键 词:更昔洛韦 HepG22.2.15细胞 HBV
文章编号:1001-5213(2000)10-0589-04
修稿时间:2000-01-13

Anti-hepatitis B virus effect of gancicloriv(GCV) in vitro
HUANG Yan Qing,GONG Zuo Jiong,CAI Hong Sheng,et al. Anti-hepatitis B virus effect of gancicloriv(GCV) in vitro[J]. Chinese Journal of Hospital Pharmacy, 2000, 20(10): 589-592
Authors:HUANG Yan Qing  GONG Zuo Jiong  CAI Hong Sheng  et al
Abstract:OBJECTIVE:To study the inhibitory effect of gancilovir(GCV) on hepatitis B virus(HBV) replication in vitro .METHODS:To evaluate inhibitory effect of GCV with HBV transfected HepG 2 2.2.15 cell line in vitro .RESULTS:GCV could remarkably reduce the secret of HBsAg and HBV DNA in HepG 2 2.2.15 cell culture medium.Southern blot analysis demonstrated that GCV could remarkably inhibit HBV replicative intermediates including covalentely closed circular DNA. GCV and not significantly affect to cell morphology,cell counting and total cellular DNA.These results indicated that GCV can inhibit HBV replication in vitro ;meanwhile,the toxic effect to cells is not significant.CONCLUSIONS:GCV,as a novel,broad spectrum nucleotide analogue has anti HBV activity,can be used further in clinical study. [
Keywords:GCV  hepatitis B virus  HepG_2 2.2.15 cell
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号